Inventor · disambiguated record
Thomas Kirkegaard Jensen
Also filed as: JENSEN THOMAS · JENSEN THOMAS K · JENSEN THOMAS KIRKEGAARD
14 granted patents·12 pending applications·70 citations·filing 2009–2025
91Inventor score
Files withORPHAZYME AS17ORPHAZYME APS3ZEVRA DENMARK AS3JENSEN THOMAS KIRKEGAARD2UNIV COLORADO REGENTS1
Top patents by PatentIndex Score
26 records- 0191US11045460B2Use of Hsp70 as a regulator of enzymatic activityORPHAZYME AS·Filed 2019·Granted Jun 29, 2021·4 cites·5 claims
- 0290US11304941B2Use of HSP70 as a regulator of enzymatic activityORPHAZYME AS·Filed 2019·Granted Apr 19, 2022·3 cites·5 claims
- 0390US9662375B2Methods for increasing intracellular activity of Hsp70JENSEN THOMAS KIRKEGAARD·Filed 2011·Granted May 30, 2017·32 cites·7 claims
- 0489US10543204B2Use of Hsp70 as a regulator of enzymatic activityORPHAZYME AS·Filed 2017·Granted Jan 28, 2020·6 cites·14 claims
- 0587US11938125B2Use of Hsp70 as a regulator of enzymatic activityZEVRA DENMARK AS·Filed 2022·Granted Mar 26, 2024·1 cites·5 claims
- 0687US9884058B2Use of Hsp70 as a regulator of enzymatic activityORPHAZYME APS·Filed 2016·Granted Feb 6, 2018·8 cites·13 claims
- 0786US9289472B2Use of HSP70 as a regulator of enzymatic activityORPHAZYME APS·Filed 2013·Granted Mar 22, 2016·10 cites·14 claims
- 0882US10532085B2Methods for increasing intracellular activity of Hsp70ORPHAZYME AS·Filed 2017·Granted Jan 14, 2020·3 cites·11 claims
- 0977US8540985B2Use of Hsp70 as a regulator of enzymatic activityJENSEN THOMAS KIRKEGAARD·Filed 2009·Granted Sep 24, 2013·2 cites·11 claims
- 1076US11253505B2Arimoclomol for treating glucocerebrosidase associated disordersORPHAZYME AS·Filed 2020·Granted Feb 22, 2022·1 cites·9 claims
- 1173US2022374361A1Methods for increasing intracellular activity of hsp70ORPHAZYME AS·Filed 2022·Application pending·0 cites
- 1271US2025387384A1Arimoclomol for treating glucocerebrosidase associated disordersZEVRA DENMARK AS·Filed 2025·Application pending·0 cites
- 1366US2022133707A1Arimoclomol for treating glucocerebrosidase associated disordersORPHAZYME AS·Filed 2022·Application pending·0 cites
- 1461US2015004151A1Use of hsp70 as a regulator of enzymatic activityORPHAZYME APS·Filed 2014·Application pending·0 cites
- 1560US11033601B2Selective inhibition of V1b for treating fatty liverUNIV COLORADO REGENTS·Filed 2018·Granted Jun 15, 2021·0 cites·3 claims
- 1659US2019111041A1Arimoclomol for treating glucocerebrosidase associated disordersORPHAZYME AS·Filed 2017·Application pending·0 cites
- 1753US11229633B2Arimoclomol formulationORPHAZYME AS·Filed 2020·Granted Jan 25, 2022·0 cites·16 claims
- 1853US2023226036A1Arimoclomol for treating gaucher diseaseORPHAZYME AS·Filed 2021·Application pending·0 cites
- 1951US10898476B2Heat shock proteins and cholesterol homeostasisORPHAZYME AS·Filed 2017·Granted Jan 26, 2021·0 cites·12 claims
- 2050US2021186949A1Heat shock proteins and cholesterol homeostasisORPHAZYME AS·Filed 2020·Application pending·0 cites
- 2149US2020188492A1Methods for increasing intracellular activity of hsp70ORPHAZYME AS·Filed 2019·Application pending·0 cites
- 2248US10709700B2Arimoclomol formulationORPHAZYME AS·Filed 2015·Granted Jul 14, 2020·0 cites·15 claims
- 2347US2022211687A1Use of arimoclomol in the treatment of niemann pick diseaseORPHAZYME AS·Filed 2021·Application pending·0 cites
- 2446US2021164997A1Hsp70 protein levels in pbmc samples as biomarker for diseaseORPHAZYME AS·Filed 2019·Application pending·0 cites
- 2545US2024115558A1Arimoclomol for the treatment of niemann pick disease, type c, in patients with er type missense mutationsZEVRA DENMARK AS·Filed 2021·Application pending·0 cites
- 2638US2020085812A1Heat shock protein inducers and frontotemporal disordersORPHAZYME AS·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Kirkegaard Jensen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →